Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Alpha-Lipoic Acid and Coenzyme Q10 Combination Ameliorates Experimental Diabetic Neuropathy by Modulating Oxidative Stress and Apoptosis Publisher Pubmed



Sadeghiyan Galeshkalami N1 ; Abdollahi M2, 3 ; Najafi R4 ; Baeeri M2 ; Jamshidzade A5 ; Falak R6 ; Davoodzadeh Gholami M6 ; Hassanzadeh G7 ; Mokhtari T8, 9 ; Hassani S2 ; Rahimifard M2 ; Hosseini A10
Authors

Source: Life Sciences Published:2019


Abstract

Aims: Diabetic neuropathy (DN) is the most common complication of diabetes. Neuroprotective effects of alpha lipoic acid (ALA) and coenzyme Q10 (CoQ10) has been previously shown in DN, but underlying mechanisms involved not been exactly found. The present study explored the neuroprotective effects of ALA and Q10 combination in experimental DN by ameliorating oxidative stress and apoptosis. Main methods: We investigated the effects of CoQ10 (10 mg/kg, orally, five weeks) and/or ALA (100 mg/kg, orally, five weeks) in STZ (45 mg/kg, i.p.)- induced DN in rats. After treatments motor function, oxidative stress biomarkers, ATP levels, expression of caspase 3 and UCP2 proteins were assessed by open-field, biochemical and ELISA methods and Western blot analysis. Dorsal root ganglion (DRG) neurons were histologically examined using H&E staining method. Key findings: ALA and/or CoQ10 treatment significantly (p < 0.05) attenuated DN – induced motor function deficiency by modulating distance moved and velocity. ALA and/or CoQ10 treatment dramatically suppressed DN – induced oxidative stress which was associated with decrease in LPO and ROS and increase in GSH and TAC in DRG neurons. ALA and/or CoQ10 was proved to prevent apoptosis and degeneration of DRG neurons, which appears to be mediated by regulating the expression of caspase 3 and UCP2 proteins, inducing ATP and improving DN–induced changes in DRG neurons. We found maximum effectiveness with ALA and CoQ10 combination on mentioned factors. Significance: These results provide a possible basis of the underlying mechanism for application of ALA and CoQ10 combination in treatment of DN. © 2018 Elsevier Inc.
Related Docs
View other Related Docs
1. Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons, Metabolic Brain Disease (2022)
2. Phosphodiesterase 4 and 7 Inhibitors Produce Protective Effects Against High Glucose-Induced Neurotoxicity in Pc12 Cells Via Modulation of the Oxidative Stress, Apoptosis and Inflammation Pathways, Metabolic Brain Disease (2018)
3. Sildenafil Protective Effects on High Glucose-Induced Neurotoxicity in Pc12 Cells: The Role of Oxidative Stress, Apoptosis, and Inflammation Pathways in an in Vitro Cellular Model for Diabetic Neuropathy, Neurological Research (2018)
Experts (# of related papers)
View all Related Experts
Ahmad Reza Dehpour (6)
Maryam Baeeri (4)
Other Related Docs
4. The Neuroprotective Effects of Melatonin Against Diabetic Neuropathy: A Systematic Review of Non-Clinical Studies, Frontiers in Pharmacology (2022)
5. Lithium Decreases Streptozocin-Induced Diabetic Neuropathy in Rats by Inhibiting of Adenosine Triphosphate (Atp) Degradation, Acta Medica Iranica (2018)
6. Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects, Fundamental and Clinical Pharmacology (2023)
7. Polyphenols for Diabetes Associated Neuropathy: Pharmacological Targets and Clinical Perspective, DARU# Journal of Pharmaceutical Sciences (2019)
8. Neuro-Protective Effects of Cerium and Yttrium Oxide Nanoparticles on High Glucose-Induced Oxidative Stress and Apoptosis in Undifferentiated Pc12 Cells, Neurological Research (2015)
9. Nano Curcumin Supplementation Reduced the Severity of Diabetic Sensorimotor Polyneuropathy in Patients With Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo- Controlled Clinical Trial, Complementary Therapies in Medicine (2019)
10. Hyperglycemia Decreased Medial Amygdala Projections to Medial Preoptic Area in Experimental Model of Diabetes Mellitus, Acta Medica Iranica (2015)
11. Effect of Coenzyme Q10 Supplementation on Diabetes Induced Memory Deficits in Rats, Metabolic Brain Disease (2019)
12. Studying Neuroprotective Effect of Atorvastatin As a Small Molecule Drug on High Glucose-Induced Neurotoxicity in Undifferentiated Pc12 Cells: Role of Nadph Oxidase, Metabolic Brain Disease (2017)
13. Cytokine Signaling in Diabetic Neuropathy: A Key Player in Peripheral Nerve Damage, Biomedicines (2025)
14. Atorvastatin Prevents the Development of Diabetic Neuropathic Nociception by Possible Involvement of Nitrergic System, Journal of Applied Biomedicine (2021)
15. The Effectiveness and Safety of Nanocurcumin Supplementation for Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes: A Randomized Double-Blind Clinical Trial, Nutrition Journal (2025)
16. Antidiabetic and Neuroprotective Effects of a Novel Repaglinide Analog, Journal of Biochemical and Molecular Toxicology (2022)
17. Anti-Inflammatory Effect of Ampk Signaling Pathway in Rat Model of Diabetic Neuropathy, Inflammopharmacology (2016)
18. The Safety and Efficacy of Stem Cell Therapy for Diabetic Peripheral Neuropathy in Animal Studies: A Systematic Review and Meta-Analysis, Neuroscience (2025)
19. Rolipram and Pentoxifylline Combination Ameliorates the Morphological Abnormalities of Dorsal Root Ganglion Neurons in Experimental Diabetic Neuropathy by Reducing Mitochondrial Dysfunction and Apoptosis, Journal of Biochemical and Molecular Toxicology (2023)
20. Cerium and Yttrium Oxide Nanoparticles and Nano-Selenium Produce Protective Effects Against H2o2-Induced Oxidative Stress in Pancreatic Beta Cells by Modulating Mitochondrial Dysfunction, Pharmaceutical Nanotechnology (2020)